MedPath

Comparitive study of the stability of oral anticoagulant therapy using phenprocoumon or warfarin.

Completed
Registration Number
NL-OMON23351
Lead Sponsor
eiden University Medical Center
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

1. No current use of anticoagulants;

2. Aged 18–85;

Exclusion Criteria

1. Pregnancy;

2. Chemotherapy;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time spent within therapeutic range, time to the first INR in range, percentage of INRs above range after initiation scheme, reaction of INR to interruption of coumarin or vitamin K administration.
Secondary Outcome Measures
NameTimeMethod
1. Bleeding complications; <br /><br>2. Thrombotic complications.
© Copyright 2025. All Rights Reserved by MedPath